Submitted by Jack Attack on Thu, 10/05/2017 - 5:03pm Incorporating Immuno-oncology Agents into Solid and Liquid Tumor Treatment Paradigms: Highlights from ASCO 2017 – Expert Discussion Group: Subscribe to groupGroup visibility: Public - accessible to all site users